https://www.live-feeds.com/feed/retraction-of-high-profile-paper-on-cancer-drug-timing-could-hand-ammo-to-china-hawksContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/retraction-of-high-profile-paper-on-cancer-drug-timing-could-hand-ammo-to-china-hawkshttps://www.live-feeds.com/feed/retraction-of-high-profile-paper-on-cancer-drug-timing-could-hand-ammo-to-china-hawks#u20255Wed, 01 Jul 2026 14:10:48 +0000Nature Medicine retracted a February 2026 paper regarding a China-based lung cancer immunotherapy trial on June 24, 2026. The study had claimed that treatment timing, specifically early morning administration, improved survival rates. The journal cited concerns over data integrity following a four-month investigation.What's confirmed:Nature Medicine retracted a February 2026 paper on a China-based lung cancer immunotherapy trial on June 24, 2026.The retracted study suggested that lung cancer survival was tied to the timing of treatment.The retraction followed a four-month investigation.The jou